Selected article for: "genome sequencing and ongoing evolution"

Author: West, Anthony P.; Wertheim, Joel O.; Wang, Jade C.; Vasylyeva, Tetyana I.; Havens, Jennifer L.; Chowdhury, Moinuddin A.; Gonzalez, Edimarlyn; Fang, Courtney E.; Di Lonardo, Steve S.; Hughes, Scott; Rakeman, Jennifer L.; Lee, Henry H.; Barnes, Christopher O.; Gnanapragasam, Priyanthi N. P.; Yang, Zhi; Gaebler, Christian; Caskey, Marina; Nussenzweig, Michel C.; Keeffe, Jennifer R.; Bjorkman, Pamela J.
Title: Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York
  • Cord-id: rl2rbz7e
  • Document date: 2021_8_9
  • ID: rl2rbz7e
    Snippet: Wide-scale SARS-CoV-2 genome sequencing is critical to tracking viral evolution during the ongoing pandemic. We develop the software tool, Variant Database (VDB), for quickly examining the changing landscape of spike mutations. Using VDB, we detect an emerging lineage of SARS-CoV-2 in the New York region that shares mutations with previously reported variants. The most common sets of spike mutations in this lineage (now designated as B.1.526) are L5F, T95I, D253G, E484K or S477N, D614G, and A701
    Document: Wide-scale SARS-CoV-2 genome sequencing is critical to tracking viral evolution during the ongoing pandemic. We develop the software tool, Variant Database (VDB), for quickly examining the changing landscape of spike mutations. Using VDB, we detect an emerging lineage of SARS-CoV-2 in the New York region that shares mutations with previously reported variants. The most common sets of spike mutations in this lineage (now designated as B.1.526) are L5F, T95I, D253G, E484K or S477N, D614G, and A701V. This lineage was first sequenced in late November 2020. Phylodynamic inference confirmed the rapid growth of the B.1.526 lineage. In concert with other variants, like B.1.1.7, the rise of B.1.526 appears to have extended the duration of the second wave of COVID-19 cases in NYC in early 2021. Pseudovirus neutralization experiments demonstrated that B.1.526 spike mutations adversely affect the neutralization titer of convalescent and vaccinee plasma, supporting the public health relevance of this lineage.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acid amplification testing: 1
    • absence presence and logistic model: 1, 2, 3, 4, 5, 6, 7
    • absence presence and low prevalence: 1, 2, 3, 4
    • absence presence and luciferase activity: 1, 2, 3, 4, 5
    • academic institution and logistic model: 1, 2, 3
    • accession number and additional sequence: 1, 2
    • acid amplification testing and low prevalence: 1, 2
    • additional sequence and luciferase ires: 1
    • logistic model and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9